Ikaria CEO Daniel Tasse elected to PhRMA board
HAMPTON, N.J. — Daniel Tasse, chairman and CEO of Ikaria Inc., has been elected to the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), according to a press release.
Headquartered in Washington, D.C., PhRMA represents the country''s leading pharmaceutical research and biotechnology companies.
In addition to his membership on the 31-person board, Tasse will serve on the PhRMA Rare Disease and Emerging Company Committees.“I’m honored to join this prestigious group of industry leaders and innovators,” said Tasse. “Through my new position on PhRMA’s Board of Directors, I look forward to helping to move forward policies that will advance the pharmaceutical industry and continue to benefit patients during this important time for our industry and our economy.”